Effects of Sarbanes-Oxley 404(B) on Biotech Innovation
Effects of Sarbanes-Oxley 404(B) on Biotech Innovation
![Effects of Sarbanes-Oxley 404(B) on Biotech Innovation](/sites/default/files/2024-04/fed-rulemaking-fullpage-one-img_0.jpg)
Effects of Sarbanes-Oxley 404(B) on Biotech Innovation
Resources for emerging growth biotech companies would be better used for science than compliance with Section 404(b), economists find.